Published by Wanda Rich
Posted on April 2, 2025
Growing Popularity of Collagen Injectables among Surgeons for Carrying Out More Effective and Faster Non-invasive Aesthetic Procedures: Fact.MR Report
The global non-invasive aesthetic treatment market has been valued at US$ 39.75 billion in 2024, as asserted in the updated industry report by Fact.MR, a market research and competitive intelligence provider. Global revenue from non-invasive aesthetic treatment solutions is analyzed to reach US$ 260 billion by 2034-end.
Non-invasive procedures, including injectables and dermal fillers, offer precise services, resulting in more natural and subtle outcomes. This is leading to a rejuvenated and natural appearance while assisting in maintaining a natural look. Less discomfort, fewer risks, and minimal downtime of non-invasive aesthetic treatment compared to traditional surgical procedures are contributing to their increased demand.
High demand for non-invasive aesthetic treatment in North America is because of the rising number of surgical procedures for aesthetic purposes. In addition, the increasing use of Botox injections for beautification purposes is also generating remunerative opportunities for market players in the region.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7162
Key Takeaway from the Market Study:
The global non-invasive aesthetic treatment market is forecasted to expand at a high-value CAGR of 20.7% from 2024 to 2034. North America is expected to account for a 36.1% share of global market revenue by the end of 2034.
“Rising acceptance of aesthetic procedures and growing influence of social media on individuals about their appearance are driving the demand for non-invasive aesthetic treatment due to less discomfort and minimal downtime,”says a Fact.MR analyst.
Presence of Skilled Experts and Personalized Services in Hospitals/Surgery Centers
Worldwide revenue from non-invasive aesthetic procedures at hospitals/surgery centers is approximated to increase at 22.3% CAGR and reach US$ 120.58 billion by the end of 2034. A comprehensive array of non-invasive aesthetic procedures is provided in hospital settings. These centers are popular due to the presence of highly skilled medical staff and experts who provide customized advice and guidance, thereby instilling high confidence and trust among patients.
Rising Popularity of Botox Injections in Aesthetic Treatments
The demand for non-invasive aesthetic treatments is being fueled by the growing acceptance of Botox injections, particularly among aging consumers. Individuals over the age of 50, especially women, are significantly driving the market for Botox-based fillers and injectables.
Primarily used to reduce facial wrinkles, Botox injections also help regulate sebaceous gland activity, minimizing excessive oil production and sweat. This, in turn, aids in preventing acne formation and improving overall skin health, further boosting their appeal in cosmetology.
Innovative Injection Techniques Driving Personalized Aesthetic Treatments
Advancements in injection technology are transforming the non-invasive aesthetic treatment market. Innovations such as micro-dosing and personalized treatment plans are enhancing precision, effectiveness, and overall patient satisfaction.
Additionally, the development of advanced delivery systems and formulations is expanding treatment options for both patients and practitioners. These innovations are making customized aesthetic solutions more accessible, ensuring tailored results that meet individual needs.
Receive a Tailored Analysis for Specific Research Solutions:https://www.factmr.com/connectus/sample?flag=S&rep_id=7162
Key Market Players:
More Valuable Insightson Offer
Fact.MR, in its new offering, presents an unbiased analysis of the non-invasive aesthetic treatment market, presenting historical demand data (2019 to 2023) and forecast statistics for the period (2024 to 2034).
The study divulges essential insights into the market based on procedure (injectables (botulinum toxin, calcium hydroxylapatite, hyaluronic acid, polymer filler, collagen), skin rejuvenation (chemical peel, laser skin resurfacing, photorejuvenation), others (hair removal, nonsurgical fat reduction, sclerotherapy, cellulite treatment)), and end user (hospitals/surgery centers, medspas, traditional spas, CHP-owned clinics), across seven major regions of the world (North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and MEA).
Explore More Studies Published by Fact.MR Research:
The global airway clearance system market size is projected to be valued at US$ 673.2 million in 2024 and climb to US$ 1.21 billion by 2034, expanding at a CAGR of 6.1% between 2024 and 2034.
The global angiography catheter market size is projected to be valued at US$ 1.57 billion in 2024 and climb to US$ 3.05 billion by 2034, expanding at a CAGR of 6.9% between 2024 and 2034.
The global animal genetics market is set to enjoy a valuation of US$ 6.3 billion in 2022 and further expand at a CAGR of 6.2% to reach US$ 11.5 billion by 2032.
Weighing the impact of key influencers, a recent report published by Fact.MR infers that the arthritis therapeutics market is estimated to grow 1.5X during the forecast period (2020 to 2027).
With the global atopic dermatitis market placed at US$ 12.73 billion in 2024, companies can expect market expansion at a CAGR of 4.3% and a valuation of US$ 19.49 billion by the end of 2034.
The global biofilms treatment market size is valued at US$ 1.55 billion in 2023 and is projected to expand at a CAGR of 7.5% to reach US$ 3.3 billion by 2033-end, according to the latest market study by skilled analysts at Fact.MR.
The global bipolar disorder therapeutics market will account for US$ 5.9 Bn in 2022 and is anticipated to reach a valuation of US$ 6.8 Bn by 2026.
Global sales of Blood Ketone Meter in 2021 was held at US$ 275.1 Mn. With 8.1%, the projected market growth from 2022 to 2032 is expected to be significantly higher than the historical growth. Blood Ketone Monitoring is expected to be the highest revenue-generating product, with a CAGR of 9.5%, from 2022 to 2032.
Explore more articles in the Research Reports category
